Comparison of Adeno-Associated Virus Pseudotype 1, 2, and 8 Vectors Administered by Intramuscular Injection in the Treatment of Murine Phenylketonuria
Published 2009 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison of Adeno-Associated Virus Pseudotype 1, 2, and 8 Vectors Administered by Intramuscular Injection in the Treatment of Murine Phenylketonuria
Authors
Keywords
-
Journal
HUMAN GENE THERAPY
Volume 21, Issue 4, Pages 463-477
Publisher
Mary Ann Liebert Inc
Online
2009-11-17
DOI
10.1089/hum.2009.127
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells
- (2009) F. Mingozzi et al. BLOOD
- Converting an injectable protein therapeutic into an oral form: Phenylalanine ammonia lyase for phenylketonuria
- (2009) Tse Siang Kang et al. MOLECULAR GENETICS AND METABOLISM
- Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy
- (2009) M. L. Brantly et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Optimized adeno-associated virus 8 produces hepatocyte-specific Cre-mediated recombination without toxicity or affecting liver regeneration
- (2008) Karen J. Ho et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Potential of AAV vectors in the treatment of metabolic disease
- (2008) I E Alexander et al. GENE THERAPY
- Enhancing transduction of the liver by adeno-associated viral vectors
- (2008) A C Nathwani et al. GENE THERAPY
- Immunity to adeno-associated virus vectors in animals and humans: a continued challenge
- (2008) A K Zaiss et al. GENE THERAPY
- Bioluminescent virion shells: new tools for quantitation of AAV vector dynamics in cells and live animals
- (2008) A Asokan et al. GENE THERAPY
- Identification of pharmacological chaperones as potential therapeutic agents to treat phenylketonuria
- (2008) Angel L. Pey et al. JOURNAL OF CLINICAL INVESTIGATION
- Recent developments in adeno‐associated virus vector technology
- (2008) Hildegard Büning et al. JOURNAL OF GENE MEDICINE
- What we know that could influence future treatment of phenylketonuria
- (2008) C. N. Sarkissian et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Safety and Efficacy of Regional Intravenous (RI) Versus Intramuscular (IM) Delivery of rAAV1 and rAAV8 to Nonhuman Primate Skeletal Muscle
- (2008) Alice Toromanoff et al. MOLECULAR THERAPY
- Correction of Murine PKU Following AAV-mediated Intramuscular Expression of a Complete Phenylalanine Hydroxylating System
- (2008) Zhaobing Ding et al. MOLECULAR THERAPY
- Recombinant Adeno-associated Virus Transduction and Integration
- (2008) Brian R Schultz et al. MOLECULAR THERAPY
- Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic Injection
- (2008) Carmela Zincarelli et al. MOLECULAR THERAPY
- Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuria
- (2008) C. N. Sarkissian et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- AAV8, 9, Rh10, Rh43 Vector Gene Transfer in the Rat Brain: Effects of Serotype, Promoter and Purification Method
- (2007) Ronald L Klein et al. MOLECULAR THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation